Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 4/20 | 0.36 |
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9714754 | 0.85 | KDM4E (0.32) | CYP3A4ALDH1A1TDP1 | |
| SCHEMBL9714774 | 0.82 | CYP3A4 (0.36) | ESR2ESR1CYP3A4TDP1 | |
| SCHEMBL9714707 | 0.80 | CYP3A4 (0.34) | CYP3A4CYP1A2TDP1 | |
| SCHEMBL10882893 | 0.77 | CYP3A4 (0.43) | CYP3A4MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL9714488 | 0.77 | CYP3A4 (0.36) | ESR2ESR1CYP3A4CYP1A2TDP1 | |
| SCHEMBL181368 | 0.76 | TRPA1 (0.46) | ESR2ESR1CYP3A4MEN1ALDH1A1 | |
| SCHEMBL15201702 | 0.74 | TP53 (0.50) | ESR2ESR1CYP3A4ALDH1A1CYP1A2 | |
| SCHEMBL9714829 | 0.74 | CYP3A4 (0.34) | CYP3A4MEN1ALDH1A1KMT2ATDP1 | |
| SCHEMBL22871613 | 0.74 | CYP3A4 (0.57) | ESR2ESR1CYP3A4MEN1KMT2A | |
| SCHEMBL9714604 | 0.73 | TDP1 (0.43) | ESR2ESR1CYP3A4ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5166210-A | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1992-11-24 | — | — | US | disclosed |
| US-5028615-A | Treatment of hypersensitivity | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-07-02 | — | — | US | disclosed |
| US-4920133-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |